Lofibra 134 mg Gate 323 (Lofibra 134 mg)
Generic Name: fenofibrate
Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule-shape and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.
Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Lofibra 134 mg Gate 323
Lofibra
- Generic Name
- fenofibrate
- Imprint
- Lofibra 134 mg Gate 323
- Strength
- 134 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gate Pharmaceuticals
- National Drug Code (NDC)
- 57844-0323
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
povidone k25,
corn starch,
sodium lauryl sulfate,
magnesium silicate,
D&C Red No. 28,
FD&C Blue No. 1,
titanium dioxide
Note: Inactive ingredients may vary.
More about Lofibra (fenofibrate)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: fibric acid derivatives
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.